Sample Report | Old Report | Not Current

Mantra Group (ASX:MTR) Share Analysis and Stock Report

MTR
March 27, 2018 FAT-AUS-867
3.94
Special
medium
H

Getting the Green Light

Mantra Group (ASX:MTR) has received approval from the key regulatory authorities for its takeover from the French hotel chain Accor Hotels. The deal remains subject to the approval of Mantra’s shareholders and approval from the Federal Court of Australia, both of which we expect to be forthcoming. Accordingly, the deal could be concluded as early as May 2018.

Mantra’s business model has been focused on serviced apartments offered through the Peppers, Mantra, Art Series and Breakfree brands.

Mantra Group (ASX:MTR) Group Locations

Source: Mantra (ASX:MTR)

Accor’s business is more hotel-style centric via the Ibis, Mercure, Sofitel and Novotel brands. This makes for an attractive combination in our view and
in October 2017, Accor made a bid for Mantra of $3.96 per share in cash (being $4.02 per share, less the final FY17 dividend).

That includes the scope for a potential special dividend with a maximum value of 23.5 cents per share to be deducted from the $3.96 headline value. Given that context, Mantra Group has not declared a dividend for the half year ended 31 December 2017.

The approximate $1.2 billion offer was unanimously approved by Mantra’s Board and the company engaged with the Foreign Investment Review Board (FIRB) and the Australian Competition and Consumer Commission (ACCC) to seek regulatory approval from these agencies. The condition relating to approval by the New Zealand Commerce Commission was waived.

Prior to approval, we were of the view that getting sign-off should be relatively smooth sailing given the fragmented nature of Australia’s hotel market. The deal would see the merger of the country’s two biggest hotel operators and combined Accor and Mantra would have over 300 hotels and 50,000 rooms, but this equates to a market share of just over 10%. This is also without factoring in the amount of disruptive competition from the likes of the AirBnb platform.

Although it took longer than expected to get the all-clear, on 8 March 2018, the ACCC announced it will not oppose the acquisition. Of the decision, Chairman Rod Sims said, “The combined Accor-Mantra will still have to compete with other international and national hotel chains, as well as many independent hotels and accommodation providers” and added, “The combined Accor-Mantra will have a large number of properties in some areas particularly in certain holiday destinations in Queensland. However, after a detailed review the ACCC has found that there are also sufficient other options nearby for visitors which will provide competition to Accor-Mantra.”

The FIRB was the next to approve the proposed transaction on 20 March 2018, with Federal Court of Australia approval and the sign off from shareholders to come. We expect both to be forthcoming. Mantra expects to distribute its Scheme Booklet to shareholders in April, with a vote in May. Subject to the satisfaction of all outstanding conditions, Mantra expects the Scheme to be implemented in May 2018.

We recommend that Members maintain their holdings in Mantra Group (ASX:MTR) as the acquisition process plays out.

Mantra Group (ASX:MTR) Share Price Chart

1H18 snapshot

Mantra Group’s operating profit and bottom line result was modestly below expectations in 1H18 despite reporting record interim revenue of $366.2 million for the six months ended 31 December 2017. That marked a $10.1 million, or 2.8% increase driven by the acquisition of 10 new properties to increase the total number of rooms across the group, increased travel to some locations and marginal increase in Revenue Per Available Room (RevPAR).

The company particularly highlighted continued domestic and international travel growth to the Queensland and New Zealand regions, along with strong demand in the CBD segment in Sydney, Canberra and Adelaide. Hawaii and Perth were adversely impacted by supply growth in the market, while Melbourne suffered somewhat due to constrained demand from new supply.

Occupancy in 1H18 was 81.9% at an average rate of $177.08, compared to the previous year’s slightly higher occupancy rate of 82.2% and slightly lower average rate of $176.33. That resulted in a marginal $0.16 or 0.1% year-on-year increase to a record RevPAR of $145.07 in 1H18.

By core segment, resorts (+1.6%) and CBD (+5.7%) revenues increased, while Central Revenue and Distribution (CR&D) segment (-6.0%) revenues declined.

Mantra Group (ASX:MTR) Revenue by Business Segment

Source: Mantra (ASX:MTR)

During the 1H18 period Mantra acquired 10 new properties, increasing available rooms by 2.6% in the six-month period. Seven were Art Series Hotel Group properties, including The Watson (Adelaide), The Olsen, The Blackman, The Cullen, The Larwill, and The Chen (all Melbourne), and The Johnson (Brisbane).

Mantra Group (ASX:MTR) Photos

Source: Mantra (ASX:MTR)

The others were the Mantra Sydney Airport Hotel (Sydney), Mantra Macarthur Hotel (Canberra) and Peppers FV (Brisbane). The Mantra Sydney Airport Hotel, a management agreement property joined the CR&D segment, while the other nine properties joined the CBD segment.

Group underlying earnings before interest, tax, depreciation, amortisation and impairment (EBITDAI) for 1H18 was $56.2 million, down $2.1 million or 3.6% from a year earlier as the underlying EBITDAI margin contracted one percentage point to 15.5%.

Resorts underlying EBITDAI decreased $1.8 million, or 6.1% to $26.3 million as the EBITDAI margin compressed 1.3 percentage points to 15.9%. New properties contributed $0.8 million in EBITDAI during the period.

Results from the US resorts operations were negatively impacted by an increase in supply pressuring room rates and a general reduction in demand for hotel rooms and conference facilities in Waikiki. Annual award payroll increases above CPI also weighed on the result somewhat.

Underlying EBITDAI in the CBD segment increased a marginal 1.3% or $0.3 million to $26.6 million, with the margin falling to 15.4% from 16.2%. Organic EBITDAI dipped 1.0%. Lower RevPAR in Melbourne (-9.5%) and Perth (-3.2%) weighed on the result. New supply in both markets was a headwind.

Mantra Group (ASX:MTR) EBITDAI by Business Segment

Source: Mantra (ASX:MTR)

CR&D underlying EBITDAI decreased 1.8% or $0.3 million to $18.5 million, with the decrease mainly due to a one-off termination payment received in the prior corresponding period which was not repeated in 1H18.

At the group level, underlying NPAT for 1H18 came in at $27.6 million, representing a $1.9 million or 6.3% year-on-year decrease. After accounting for transaction costs and costs of the proposed acquisition by Accor, statutory NPAT of $25.1 million was $5.4 million, or 17.7% lower than in 1H17.

Mantra Group (ASX:MTR) Financials

Source: Mantra (ASX:MTR)

While Mantra’s financial results are typically front-heavy, the Commonwealth Games is expected to drive stronger results in the second half of the fiscal year. Some 23 of the group’s hotels are located on the Gold Coast, positioning Mantra to participate in the economic boost to the region.

Mantra Group (ASX:MTR) Share Price Chart

Summary

Although slower than initially expected, the takeover of Mantra by Accor has progressed and obtained key approvals from the FIRB and ACCC.
Mantra expects to distribute its Scheme Booklet to shareholders in April and have a shareholder vote in May. Subject to the satisfaction of all outstanding conditions including shareholder approval and sign off from the Federal Court, Mantra expects the Scheme to be implemented in May 2018.

Mantra has the scope for a potential special dividend with a maximum value of 23.5 cents per share to be deducted from the $3.96 headline value of Accor’s bid. Given that context, Mantra Group has not declared a dividend for the half year ended 31 December 2017.

Mantra (ASX:MTR) will remain held in the Fat Prophets portfolio at this juncture.

Disclosure: Mantra (ASX:MTR) is held in the Fat Prophets Global Contrarian Fund, and the Fat Prophets Small/Mid-Cap Model Portfolio.

For Fat Prophets’ current equity research and membership options, visit our Products page.

About this archived stock report

This is an archived Fat Prophets equity research stock report and share analysis. It does not constitute current investment advice, financial product advice, or a recommendation to buy, sell or hold any financial product. It is provided for historical reference only, and reflects the market conditions, company information, forecasts and opinions available at its original publication date. The information may no longer be current or applicable. Past performance is not a reliable indicator of future performance. This is general information only and does not take into account your objectives, financial situation or needs. Before acting on anything in this report, you should consider its appropriateness to your circumstances and seek advice from a licensed financial adviser.

DISCLAIMER Fat Prophets has made every effort to ensure the reliability of the views and recommendations expressed in the reports published on its websites. Fat Prophets research is based upon information known to us or which was obtained from sources which we believed to be reliable and accurate at time of publication. However, like the markets, we are not perfect. This report is prepared for general information only, and as such, the specific needs, investment objectives or financial situation of any particular user have not been taken into consideration. Individuals should therefore discuss, with their financial planner or advisor, the merits of each recommendation for their own specific circumstances and realise that not all investments will be appropriate for all subscribers. To the extent permitted by law, Fat Prophets and its employees, agents and authorised representatives exclude all liability for any loss or damage (including indirect, special, or consequential loss or damage) arising from the use of, or reliance on, any information within the report whether or not caused by any negligent act or omission. If the law prohibits the exclusion of such liability, Fat Prophets hereby limits its liability, to the extent permitted by law, to the resupply of the said information or the cost of the said resupply.

Funds Management – In addition to the listed fund FPC, Fat Prophets Pty Ltd manages the separately managed accounts, namely Concentrated Australian Shares, Australian Shares Income, Small Midcap, Global Opportunities, Mining & Resources, and Asian Shares. These SMAs are managed under their own mandates by the fund managers, and this is independent to the research reports.

Staff trading – Fat Prophets Pty Ltd, its directors, employees and associates of Fat Prophets may hold interests in many ASX-listed Australian companies which may or may not be mentioned or recommended in the Fat Prophets newsletter. These positions may change at any time, without notice. To manage the conflict between personal dealing and newsletter recommendations the directors, employees, and associates of Fat Prophets Pty Ltd cannot knowingly trade in a stock 48 hours either side of a buy or sell recommendation being made in the Fat Prophets newsletter. Staff trades are pre-approved by an appointed staff trading compliance officer to ensure compliance with the staff trading policy.

For positions that directors and/or associates of the Fat Prophets group of companies currently hold in, please click here.

Fat Prophets Logo

Stock Disclosure

ASX- Listed Australian Stocks:
29M.AU, ANN.AU, ANZ.AU, BPT.AU, BWP.AU, CKF.AU, CBA.AU, EVN.AU, FID.AU, FMG.AU, GOR.AU, GMG.AU, GNC.AU, HUB.AU, ILU.AU, IGO.AU, JHX.AU, MGR.AU, NAB.AU, PAR.AU, QBE.AU, RRL.AU, S32.AU, SBM.AU, TLS.AU, TUA.AU, WES.AU, WBC.AU, WHC.AU, XRO.AUX, AGL.AX, AMC.AX, BHP.AX, CSL.AX, DMP.AX, GDG.AX, WIRE.AX, ATOM.AX, MQG.AX, NIC.AX, NST.AX, ORI.AX, PDN.AX, RMS.AX, RPL.AX, SFR.AX, STO.AX, SUN.AX, VAU.AX, WTC.AX, WDS.AX, GMD.AX, CSC.AX, RIO.AX, GTK.AX, SPK.AX & NEM.AX

International Stocks:
BIDU.CN, 9888.CN, 1211.CN, 268.CN, 3690.HK, 1818.HK, 9618.CN, ENX.FR, BT.A.GB, GENI.GB, FRES.GB, 9988.HK, 2282.HK, 700.HK, 1128.HK, 1876.HK, 8750, 7011.T, 8306.JP, 8031.T, 8411.T, 3994.T, 7974.T, 8604.JP, 8308, 6758.JP, 8316.JP, 8331.T, JP.8308, HEM.SE, GRAB.SG, BABA.K, GOOG.US, AAPL.US, CDE.US, CPNG.K, FLTRF.L, SIL, URA, BZ.O, MSFT.US, SBSW.K, 2840.HK, TME, GDX, GDXJ.US, YUMC.K, Z.O, IMPUY & ANGPY